CERo Therapeutics Holdings, Inc.(CERO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CERO CERo Therapeutics Holdings, Inc.

交易中 05-07 13:33:38 EDT

0.6896

-0.0443

-6.04%

最高0.7350	最低0.6802	成交量38.54万
今开0.7200	昨收0.7339	日振幅7.47%
总市值371.05万	流通市值302.16万	总股本538.07万
成交额26.74万	换手率8.79%	流通股本438.17万
市净率-0.73	ROE--	每股收益-27.84
52周最高138.00	52周最低0.5338	市盈率-0.02
股息0.00	股息收益率0.00	ROA-178.66%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CERO","market":"US","secType":"STK","nameCN":"CERo Therapeutics Holdings, Inc.","latestPrice":0.6896,"timestamp":1746639088593,"preClose":0.7339,"halted":0,"volume":385357,"delay":0,"floatShares":4381676,"shares":5380723,"eps":-27.83886,"marketStatus":"交易中","change":-0.0443,"latestTime":"05-07 13:33:36 EDT","open":0.72,"high":0.735,"low":0.6802,"amount":267417.5652932,"amplitude":0.07467,"askPrice":0.702,"askSize":500,"bidPrice":0.6892,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-27.83886,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746648000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.7339,"preHourTrading":{"tag":"盘前","latestPrice":0.74,"preClose":0.7339,"latestTime":"09:26 EDT","volume":12583,"amount":9302.362756600001,"timestamp":1746624419717},"postHourTrading":{"tag":"盘后","latestPrice":0.7057,"preClose":0.7339,"latestTime":"19:57 EDT","volume":28453,"amount":20421.9796,"timestamp":1746575879865},"volumeRatio":1.684444},"requestUrl":"/m/hq/s/CERO","defaultTab":"news","newsList":[{"id":"2533261546","title":"Cero Therapeutics Holdings, Inc.5月6日成交额为19.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533261546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533261546?lang=zh_cn&edition=full","pubTime":"2025-05-07 09:21","pubTimestamp":1746580880,"startTime":"0","endTime":"0","summary":"美东时间2025年5月6日，Cero Therapeutics Holdings, Inc.成交额为19.76万美元，成交额较昨日减少52.82%，当日成交量为26.66万股。Cero Therapeutics Holdings, Inc.于2025年5月6日跌7.1%，报0.734美元，该股过去5个交易日跌22.58%，年初至今跌87.77%，过去60日跌62.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-06|19.76万|-52.82%|26.66万|#|2025-05-05|41.88万|49.28%|53.01万|#|2025-05-02|28.05万|-22.13%|31.84万|#|2025-05-01|36.03万|30.82%|40.79万|#|2025-04-30|27.54万|-27.17%|30.52万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507092122a6d5aa32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507092122a6d5aa32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CERO","BK4139","LENZ"],"gpt_icon":0},{"id":"2532012905","title":"Cero Therapeutics Holdings, Inc.4月30日成交额为27.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532012905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532012905?lang=zh_cn&edition=full","pubTime":"2025-05-01 09:21","pubTimestamp":1746062482,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，Cero Therapeutics Holdings, Inc.成交额为27.54万美元，成交额较昨日减少27.17%，当日成交量为30.52万股。Cero Therapeutics Holdings, Inc.于2025年4月30日跌6.11%，报0.89美元，该股过去5个交易日涨11.38%，年初至今跌85.17%，过去60日跌55.51%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-30|27.54万|-27.17%|30.52万|#|2025-04-29|37.81万|-32.41%|40.25万|#|2025-04-28|55.94万|-66.98%|62.33万|#|2025-04-25|169.43万|-98.06%|189.96万|#|2025-04-24|8750.42万|11309.51%|7179.93万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501092131a6cf84a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501092131a6cf84a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CERO","BK4007"],"gpt_icon":0},{"id":"2531105545","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大跌5.02%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531105545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531105545?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:52","pubTimestamp":1746021127,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时52分，Cero Therapeutics Holdings, Inc.股票出现波动，股价快速下挫5.02%。截至发稿，该股报0.900美元/股，成交量6.7673万股，换手率1.21%，振幅2.26%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043021520794e90b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043021520794e90b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CERO","BK4007"],"gpt_icon":0},{"id":"2531374121","title":"Cero Therapeutics Holdings, Inc.4月29日成交额为37.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531374121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531374121?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:21","pubTimestamp":1745976061,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Cero Therapeutics Holdings, Inc.成交额为37.81万美元，成交额较昨日减少32.41%，当日成交量为40.25万股。Cero Therapeutics Holdings, Inc.于2025年4月29日涨2.46%，报0.948美元，该股过去5个交易日涨25.04%，年初至今跌84.2%，过去60日跌55.71%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|37.81万|-32.41%|40.25万|#|2025-04-28|55.94万|-66.98%|62.33万|#|2025-04-25|169.43万|-98.06%|189.96万|#|2025-04-24|8750.42万|11309.51%|7179.93万|#|2025-04-23|76.69万|26.74%|94.27万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430092105a6ce12c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430092105a6ce12c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CERO","LENZ","BK4007"],"gpt_icon":0},{"id":"2531172753","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘急速上涨5.79%报0.979美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531172753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531172753?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:53","pubTimestamp":1745934827,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时53分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速上涨5.79%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.32%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为138.21%、56.57%、22.61%，振幅较大的相关个股有Spruce Biosciences, Inc.、Cyclacel Pharmaceuticals, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为31.68%、26.68%、22.81%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215347a6cd6f66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215347a6cd6f66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4007","BK4139"],"gpt_icon":0},{"id":"2531954213","title":"Cero Therapeutics Holdings, Inc.4月28日成交额为55.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531954213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531954213?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:20","pubTimestamp":1745889645,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，Cero Therapeutics Holdings, Inc.成交额为55.94万美元，成交额较昨日减少66.98%，当日成交量为62.33万股。Cero Therapeutics Holdings, Inc.于2025年4月28日涨3.92%，报0.925美元，该股过去5个交易日涨44.98%，年初至今跌84.58%，过去60日跌53.52%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-28|55.94万|-66.98%|62.33万|#|2025-04-25|169.43万|-98.06%|189.96万|#|2025-04-24|8750.42万|11309.51%|7179.93万|#|2025-04-23|76.69万|26.74%|94.27万|#|2025-04-22|60.52万|411.46%|84.69万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092050a46b3cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092050a46b3cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2530139541","title":"Cero Therapeutics Holdings, Inc.4月25日成交额为169.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530139541?lang=zh_cn&edition=full","pubTime":"2025-04-26 09:20","pubTimestamp":1745630429,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，Cero Therapeutics Holdings, Inc.成交额为169.43万美元，成交额较昨日减少98.06%，当日成交量为189.96万股。Cero Therapeutics Holdings, Inc.于2025年4月25日跌19.81%，报0.89美元，该股过去5个交易日涨44.26%，年初至今跌85.16%，过去60日跌54.12%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|169.43万|-98.06%|189.96万|#|2025-04-24|8750.42万|11309.51%|7179.93万|#|2025-04-23|76.69万|26.74%|94.27万|#|2025-04-22|60.52万|411.46%|84.69万|#|2025-04-21|11.83万|26.96%|18.83万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426092039a6c8c521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426092039a6c8c521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CERO","BK4139"],"gpt_icon":0},{"id":"2530139766","title":"Cero Therapeutics Holdings, Inc.股价重挫13.52% 市值跌69.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530139766?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:31","pubTimestamp":1745587908,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分，Cero Therapeutics Holdings, Inc.股票出现波动，股价急速下跌13.52%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。消息层面，截至21时31分，《D. Boral Capital：维持CERo Therapeutics Hldgs评级》资讯为影响Cero Therapeutics Holdings, Inc.的重要信息。该信息摘要如下：D.Boral Capital：维持CERo Therapeutics Hldgs评级，由买入调整至买入评级,目标价由11.00美元调整至11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213148a6c81d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213148a6c81d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2530486559","title":"Cero Therapeutics Holdings, Inc.4月24日成交额为8750.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530486559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530486559?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:20","pubTimestamp":1745544012,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，Cero Therapeutics Holdings, Inc.成交额为8750.42万美元，成交额较昨日增加11309.51%，当日成交量为7179.93万股。Cero Therapeutics Holdings, Inc.于2025年4月24日涨38.85%，报1.11美元，该股过去5个交易日涨85.93%，年初至今跌81.5%，过去60日跌39.34%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|8750.42万|11309.51%|7179.93万|#|2025-04-23|76.69万|26.74%|94.27万|#|2025-04-22|60.52万|411.46%|84.69万|#|2025-04-21|11.83万|26.96%|18.83万|#|2025-04-17|9.32万|-31.44%|15.85万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425092021a6c756a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425092021a6c756a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CERO","LENZ","BK4007"],"gpt_icon":0},{"id":"2529680446","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘大幅上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529680446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529680446?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:35","pubTimestamp":1745415343,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时35分，Cero Therapeutics Holdings, Inc.股票出现异动，股价大幅拉升5.57%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。消息层面，截至21时35分，《D. Boral Capital：维持CERo Therapeutics Hldgs评级》资讯为影响Cero Therapeutics Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213543a6c53e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213543a6c53e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2529501414","title":"D. Boral Capital：维持CERo Therapeutics Hldgs评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2529501414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529501414?lang=zh_cn&edition=full","pubTime":"2025-04-23 19:32","pubTimestamp":1745407935,"startTime":"0","endTime":"0","summary":"D.Boral Capital：维持CERo Therapeutics Hldgs(CERO.US)评级，由买入调整至买入评级,目标价由11.00美元调整至11.00美元。CERo Therapeutics(CERO.US)公司简介：CERo Therapeutics Holdings Inc是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。其专有的T细胞工程方法使其能够将先天免疫和适应性免疫的某些理想特征整合到单一的治疗结构中，旨在利用人体的全部免疫功能，来实现优化的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423194241a463dc1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423194241a463dc1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","LENZ"],"gpt_icon":0},{"id":"2529586828","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大涨6.36%报0.679美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529586828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529586828?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:31","pubTimestamp":1745328680,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时31分，Cero Therapeutics Holdings, Inc.股票出现波动，股价急速上涨6.36%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，阿诺医药、亚盛医药、Ibio, Inc.涨幅较大，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ibio, Inc.较为活跃，换手率分别为158.60%、94.68%、34.16%，振幅较大的相关个股有Vincerx Pharma, Inc.、Revelation Biosciences, Inc.、Xbiotech Inc.，振幅分别为16.80%、9.55%、7.24%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221312094de31e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221312094de31e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4007","BK4139"],"gpt_icon":0},{"id":"2528749374","title":"Cero Therapeutics Holdings, Inc.盘中异动 大幅下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528749374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528749374?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:55","pubTimestamp":1744898131,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时55分，Cero Therapeutics Holdings, Inc.股票出现异动，股价大幅下挫5.53%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为473.19%、152.79%、86.08%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Channel Therapeutics Corporation、Uniqure N.V.，振幅分别为43.27%、37.45%、17.25%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215532973b5825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215532973b5825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2527449637","title":"Cero Therapeutics Holdings, Inc.股价重挫13.56% 市值跌9.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527449637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527449637?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:55","pubTimestamp":1744728938,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时55分，Cero Therapeutics Holdings, Inc.股票出现异动，股价急速下跌13.56%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Skye Bioscience, Inc.涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为985.03%、543.75%、233.46%，振幅较大的相关个股有Skye Bioscience, Inc.、Dogwood Therapeutics, Inc.、Mural Oncology Plc，振幅分别为171.53%、91.33%、86.41%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415225538a6bb5ffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415225538a6bb5ffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2516637837","title":"Cero Therapeutics Holdings, Inc.盘中异动 急速下跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637837?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:03","pubTimestamp":1741014204,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时03分，Cero Therapeutics Holdings, Inc.股票出现波动，股价大幅跳水5.96%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为985.13%、124.43%、98.85%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230324a25d49a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230324a25d49a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","LENZ","BK4139"],"gpt_icon":0},{"id":"2514387468","title":"Cero Therapeutics Holdings, Inc.盘中异动 临近午盘快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387468?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:31","pubTimestamp":1740673907,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时31分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速拉升5.12%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Alpha Tau Medical Ltd C/Wts 、Heron Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1663.56%、270.60%、113.10%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Quoin Pharmaceuticals Ltd、Pds Biotechnology Corporation，振幅分别为86.14%、47.79%、45.45%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003147abdf8b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003147abdf8b8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CERO"],"gpt_icon":0},{"id":"2514905390","title":"Cero Therapeutics Holdings, Inc.盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514905390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514905390?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:38","pubTimestamp":1740494281,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时38分，Cero Therapeutics Holdings, Inc.股票出现波动，股价急速下挫5.39%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为810.74%、577.02%、501.32%，振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Moleculin Biotech, Inc.，振幅分别为100.27%、33.50%、20.56%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223801a25388be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223801a25388be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2513208927","title":"Cero Therapeutics Holdings, Inc.盘中异动 股价大跌6.67%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513208927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513208927?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:37","pubTimestamp":1740407820,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时37分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速下跌6.67%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aditxt, Inc.、Pepgen Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为43.84%、42.36%、24.48%，振幅较大的相关个股有Pepgen Inc.、Gossamer Bio, Inc.、Summit Therapeutics Inc.，振幅分别为85.40%、14.69%、14.51%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223700abdb0f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223700abdb0f32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2513311296","title":"Cero Therapeutics Holdings, Inc.盘中异动 急速下挫6.83%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513311296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513311296?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148291,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Cero Therapeutics Holdings, Inc.股票出现波动，股价急速跳水6.83%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.30%、61.25%、19.11%，振幅较大的相关个股有Osr Holdings, Inc.、蓝鸟生物、Aspire Biopharma Holdings, Inc.，振幅分别为14.17%、11.05%、10.55%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223131abd7af72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223131abd7af72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2512165377","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘快速下挫6.80%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165377?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:36","pubTimestamp":1739889366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时36分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速下跌6.80%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为286.19%、100.98%、75.77%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为34.04%、22.30%、20.73%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223607abd3b041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223607abd3b041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CERO","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cero.bio","stockEarnings":[{"period":"1week","weight":-0.2257},{"period":"1month","weight":0.0263},{"period":"3month","weight":-0.6256},{"period":"6month","weight":-0.896},{"period":"1year","weight":-0.9946},{"period":"ytd","weight":-0.8777}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.1059},{"period":"3month","weight":-0.0752},{"period":"6month","weight":-0.0618},{"period":"1year","weight":0.0818},{"period":"ytd","weight":-0.0465}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CERo Therapeutics Holdings, Inc.于2016年9月23日在特拉华州注册成立。CERo是一家创新的免疫治疗公司，致力于推动下一代工程T细胞疗法的开发，以治疗癌症。其专有的T细胞工程方法使其能够将先天性免疫和适应性免疫的某些理想特征整合到单一治疗结构中，旨在调动人体的全部免疫库以实现优化的癌症治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.154276},{"month":2,"riseRate":0.5,"avgChangeRate":-0.236815},{"month":3,"riseRate":0.75,"avgChangeRate":-0.126046},{"month":4,"riseRate":0.75,"avgChangeRate":-0.073012},{"month":5,"riseRate":0.25,"avgChangeRate":-0.131965},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.223411},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.161759},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.060279},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.086633},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.023845},{"month":11,"riseRate":0.666667,"avgChangeRate":0.418767},{"month":12,"riseRate":0.5,"avgChangeRate":-0.169054}],"exchange":"NASDAQ","name":"CERo Therapeutics Holdings, Inc.","nameEN":"CERo Therapeutics Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.3","shortVersion":"4.33.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CERo Therapeutics Holdings, Inc.(CERO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CERo Therapeutics Holdings, Inc.(CERO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CERo Therapeutics Holdings, Inc.,CERO,CERo Therapeutics Holdings, Inc.股票,CERo Therapeutics Holdings, Inc.股票老虎,CERo Therapeutics Holdings, Inc.股票老虎国际,CERo Therapeutics Holdings, Inc.行情,CERo Therapeutics Holdings, Inc.股票行情,CERo Therapeutics Holdings, Inc.股价,CERo Therapeutics Holdings, Inc.股市,CERo Therapeutics Holdings, Inc.股票价格,CERo Therapeutics Holdings, Inc.股票交易,CERo Therapeutics Holdings, Inc.股票购买,CERo Therapeutics Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CERo Therapeutics Holdings, Inc.(CERO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CERo Therapeutics Holdings, Inc.(CERO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}